PMP22 and Charcot-Marie-Tooth disease type 1A: Visigalli et al. reported that alterations in glycerophospholipid and sphingolipid metabolism, detected in the myelin-enriched fraction and sciatic nerve tissue of CMT1A transgenic rats, could also be identified in the serum from both rats and CMT1A patients.